Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans

Figure 6 Serum TGF-β1 concentrations in non-alcoholic CP for each factor. Serum TGF-β1 concentrations were measured in patients with non-alcoholic CP (n = 57) by ELISA. A: Serum TGF-β1 concentrations for each stage of severity: Healthy control (HE, n = 116), mild severity (MI, n = 33), moderate severity (MO, n = 19) and severe (SE, n = 5); B: Serum TGF-β1 concentrations for each imaging test score: Healthy control (HE, n = 116), score 1 for imaging tests score (I1, n = 33), score 2 for imaging tests score (I2, n = 15) and score < 3 for imaging tests score (< I3, n = 9); C: Serum TGF-β1 concentrations for each score for exocrine function. Healthy control (HC, n = 116), score 0 for exocrine function (E0, n = 16), score 1 for exocrine function (E1, n = 37) and score > 2 for exocrine function (> E2, n = 4). Bars represent the mean ± SD. ^aP < 0.05 vs healthy control.